News


  • 2018 Top 10 Global Orthopedic Device Firms

    2018 Top 10 Global Orthopedic Device Firms

    Robotics and leadership changes defined the 2017 fiscal year among the largest orthopedic firms.
    ODT Staff 08.15.18

  • 1. Stryker Corp.

    1. Stryker Corp.

    $12.4 Billion KEY EXECUTIVES: Kevin A. Lobo, Chairman and CEO Glenn S. Boehnlein, Vice President, CFO Lonny J. Carpenter, Group President and advisor to the CEO Viju Menon, Group President, Global Quality and Operations David K. Floyd, Group…
    08.15.18

  • 2. DePuy Synthes

    2. DePuy Synthes

    $9.3 Billion KEY EXECUTIVES: Alex Gorsky, Chairman and CEO Dominic J. Caruso, Exec. VP and CFO Jennifer Taubert, Company Group Chairman, Johnson & Johnson Ashley McEvoy, Exec. VP, Worldwide Chairman, Medical Devices Sandra E. Peterson, Ex…
    08.15.18

  • 3. Zimmer Biomet

    3. Zimmer Biomet

    $7.8 Billion KEY EXECUTIVES: Bryan C. Hanson, President and CEO Daniel P. Florin, Exec. VP and CFO Aure Bruneau, Group President, Spine, CMF, Thoracic and Surgery Assisting Technology David A. Nolan Jr., Group President, Biologics, Extremities…
    08.15.18

  • 4. Smith & Nephew

    4. Smith & Nephew

    $4.8 Billion KEY EXECUTIVES: Roberto Quarta, Chairman Namal Nawana, CEO Graham Baker, CFO Catheryn O’Rourke, Chief Legal Officer Rodrigo Bianchi, President, International Markets Vasant Padmanabhan, President of Research & Developm…
    08.15.18

  • 5. Medtronic (Spine Division)

    5. Medtronic (Spine Division)

    $2.6 Billion KEY EXECUTIVES: Omar Ishrak, Chairman and CEO Michael J. Coyle, Exec. VP and Group President, Cardiac and Vascular Group Hooman C. Hakami, Exec. VP and Group President, Diabetes Group Bob White, Exec. VP and Group President, Minim…
    08.15.18

  • 6. DJO Global

    6. DJO Global

    $1.2 Billion KEY EXECUTIVES: Brady R. Shirley, President, CEO, and Director Mike Eklund, CFO and COO Toby Bost, President, DJO Global Consumer Business W. Mark Dorris, President, Bracing & Supports Jeffery A. McCaulley, Global President,…
    08.15.18

  • 7. NuVasive Inc.

    7. NuVasive Inc.

    $1 Billion KEY EXECUTIVES: Greg Lucier, Chairman and CEO Rajesh Asarpota, Exec. VP and CFO Skip Kiil, Exec. VP, Global Commercial Pete Leddy, Exec. VP, People and Culture Matt Link, Exec. VP, Strategy, Technology, and Corporate Development S…
    08.15.18

  • 8. Wright Medical

    8. Wright Medical

    $745 Million KEY EXECUTIVES: Robert J. Palmisano, President and CEO Lance A. Berry, Sr. VP and CFO Robert P. Burrows, Sr. VP, Supply Chain J. Wesley Porter, Sr. VP and Chief Compliance Officer Julie D. Tracy, Sr. VP and Chief Communications O…
    08.15.18

  • 9. Globus Medical

    9. Globus Medical

    $636 Million KEY EXECUTIVES: David C. Paul, Exec. Chairman David M. Demski, CEO Anthony L. Williams, President Daniel T. Scavilla, Sr. VP and CFO Eric Ian Schwartz, Sr. VP and General Counsel NUMBER OF EMPLOYEES: 1,500 GLOBAL HEADQUARTE…
    08.15.18

  • 10. Össur Hf

    10. Össur Hf

    $569 Million KEY EXECUTIVES: John Sigurdsson, President and CEO Sveinn Sölvason, CFO Egill Jónsson, EVP of Manufacturing and Operations Gudjon G. Karason, EVP of Clinics Margrét Lára Friðriksdóttir, EVP of…
    08.15.18

  • Effects of MEDDEV Revision 4 on Clinical Evaluation Reports (Part 2)

    Effects of MEDDEV Revision 4 on Clinical Evaluation Reports (Part 2)

    Whether writing a clinical evaluation report (CER) for a new device or updating one for an existing device, compliance with MEDDEV 2.7/1 Revision 4 requirements is integral. As part of the general planning associated with CERs, first perform a gap as…
    Jonathan Gimbel, Director, Regulatory and Quality Solutions LLC (R&Q) 08.15.18

  • Innovation in the 510(k) Space: A Case for Incrementalism

    Innovation in the 510(k) Space: A Case for Incrementalism

    Although the term “innovative technology” often evokes images of a breakthrough, radical discovery, or inventive cure-all, the certainty associated with incremental improvements to established, higher-risk technologies such as implantable…
    Samuel Pollard, Senior Regulatory Associate, Musculoskeletal Clinical Regulatory Advisors 08.15.18

  • Spine/Neurology
    Zavation Launches Facet Screw and Sacroiliac Screw Systems

    Zavation Launches Facet Screw and Sacroiliac Screw Systems

    The Zavation SI System is designed to be a complete fixation system to stabilize the sacroiliac joint.
    PR Newswire 08.15.18

  • FDA’s Educational Opportunities Abound

    FDA’s Educational Opportunities Abound

    As a former U.S. Food and Drug Administration (FDA) reviewer, I have spent a considerable amount of time learning the system from the “inside.” There are many avenues of training offered by the FDA, and if you know where to look, you may…
    Elizabeth O’Keeffe, Ph.D., Director, Engineering and Technical Services, Secure BioMed Evaluations 08.15.18

  • Stoking the Corner Office Compensation Controversy

    Stoking the Corner Office Compensation Controversy

    If only the real world functioned as it does in academia. Or in human imagination. Consider the possibilities: world peace, racial/gender harmony, financial security, and perfect health are just a few that come to mind. Even eternal youth wouldn&r…
    Michael Barbella, Managing Editor 08.15.18

  • Bracing/Prosthetics | Trauma/Sports
    medi USA Introduces Genumedi PSS for Knee Pain

    medi USA Introduces Genumedi PSS for Knee Pain

    Relieves tension on the insertions of the patellar ligament to relieve pain at the tip of the kneecap.
    PR Newswire 08.14.18

  • Materials | Trauma/Sports
    Self-Fitting Scaffold Promotes Bone Regeneration

    Self-Fitting Scaffold Promotes Bone Regeneration

    Until now, no bone scaffold in commercial market possesses such shape memory self-fitting effect.
    The Hong Kong Polytechnic University 08.14.18

  • OrthoPediatrics Corp. Expanding its Headquarters

    OrthoPediatrics Corp. Expanding its Headquarters

    Company is creating additional open-concept office space and dedicated training and education facilities.
    Globe Newswire 08.14.18

  • Biologics
    MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

    MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

    The company's products are classified as a biological Down Under.
    PR Newswire 08.13.18